| 1. |
劉又寧,佘丹陽,孫鐵英,等.中國1998年至2007年臨床確診的肺真菌病患者的多中心回顧性調查.中華結核和呼吸雜志,2011,34(2):86-90.
|
| 2. |
Patterson TF,Kirkpatrick WR,White M,et al.Invasive aspergillosis:disease spectrum,treatment practices,and outcomes.I3 Aspergillus Study Group.Medicine (Baltimore),2000,79(4):250-260.
|
| 3. |
Denning DW.Invasive aspergillosis.Clin Infect Dis,1998,26(4):781-803.
|
| 4. |
Marr KA,Patterson T,Denning D.Aspergillosis:pathogenesis,clinical manifestations,and therapy.Infect Dis Clin North Am,2002,16(4):875-94,vi.
|
| 5. |
Benjamin DK Jr,Miller WC,Bayliff S,et al.Infections diagnosed in the first year after pediatric stem cell transplantation.Pediatr Infect Dis J,2002,21(3):227-234.
|
| 6. |
Grow WB,Moreb JS,Roque D,et al.Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.Bone Marrow Transplant,2002,29(1):15-19.
|
| 7. |
Marr KA,Carter RA,Boeckh M,et al.Invasive aspergillosis in allogeneic stem cell transplant recipients:changes in epidemiology and risk factors.Blood,2002,100(13):4358-4366.
|
| 8. |
Perfect JR,Cox GM,Lee JY,et al.The impact of culture isolation of Aspergillus species:A hospital-based survey of aspergillosis.Clin Infect Dis,2001,33(11):1824-1833.
|
| 9. |
Walsh TJ,Groll AH.Overview:non-fumigatus species of Aspergillus:perspectives on emerging pathogens in immunocompromised hosts.Curr Opin Investig Drugs,2001,2(10):1366-1367.
|
| 10. |
Kontoyiannis DP,Lewis RE,May GS,et al.Aspergillus nidulans is frequently resistant to amphotericin B.Mycoses,2002,45(9-10):406-407.
|
| 11. |
Lass-Florl C,Rath P,Niederwieser D,et al.Aspergillus terreus infections in haematological malignancies:molecular epidemiology suggests association with in-hospital plants.J Hosp Infect,2000,46(1):31-35.
|
| 12. |
Steinbach WJ,Benjamin DK Jr,Kontoyiannis DP,et al.Infections due to Aspergillus terreus:a multicenter retrospective analysis of 83 cases.Clin Infect Dis,2004,39(2):192-198.
|
| 13. |
Sutton DA,Sanche SE,Revankar SG,et al.In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus,with a head-to-head comparison to voriconazole.J Clin Microbiol,1999,37(7):2343-2345.
|
| 14. |
Walsh TJ,Petraitis V,Petraitiene R,et al.Experimental pulmonary aspergillosis due to Aspergillus terreus:pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.J Infect Dis,2003,188(2):305-319.
|
| 15. |
Mennink-Kersten MA,Donnelly JP,Verweij PE.Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.Lancet Infect Dis,2004,4(6):349-357.
|
| 16. |
Sulahian A,Touratier S,Ribaud P.False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.N Engl J Med,2003,349(24):2366-2367.
|
| 17. |
Viscoli C,Machetti M,Cappellano P,et al.False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.Clin Infect Dis,2004,38(6):913-916.
|
| 18. |
Mennink-Kersten MA,Klont RR,Warris A,et al.Bifidobacterium lipoteichoic acid and false ELISA reactivity in Aspergillus antigen detection.Lancet,2004,363(9405):325-327.
|
| 19. |
Adam O,Auperin A,Wilquin F,et al.Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies.Clin Infect Dis,2004,38(6):917-920.
|
| 20. |
Verweij PE,Mennink-Kersten MASH.Issues with galactomannan testing.Med Mycol,2006,44(Suppl 1):S179-83.
|
| 21. |
Marty FM,Lowry CM,Lempitski SJ,et al.Reactivity of (1-->13)-beta-D-glucan assay with commonly used intravenous antimicrobials.Antimicrob Agents Chemother,2006,50(10):3450-3453.
|
| 22. |
Cornely OA,Maertens J,Bresnik M,et al.Liposomal amphotericin B as initial therapy for invasive mold infection:a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).Clin Infect Dis,2007,44(10):1289-1297.
|
| 23. |
Chowdhary A,Kathuria S,Xu J,et al.Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health.PLoS Pathog,2013,9(10):e1003633.
|
| 24. |
Snelders E,van der Lee HA,Kuijpers J,et al.Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.PLoS Med,2008,5(11):e219.
|
| 25. |
Sipsas NV,Kontoyiannis DP.Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies.Clin Infect Dis,2006,42(11):1584-1591.
|
| 26. |
Denning DW,Marr KA,Lau WM,et al.Micafungin (FK463),alone or in combination with other systemic antifungal agents,for the treatment of acute invasive aspergillosis.J Infect,2006,53(5):337-349.
|
| 27. |
Roilides E,Katsifa H,Walsh TJ.Pulmonary host defences against Aspergillus fumigatus.Res Immunol,1998,149(4-5):454-465.
|
| 28. |
Stevens DA.Th1/Th2 in aspergillosis.Med Mycol,2006,44(Suppl 1):S229-235.
|
| 29. |
Yeghen T,Kibbler CC,Prentice HG,et al.Management of invasive pulmonary aspergillosis in hematology patients:a review of 87 consecutive cases at a single institution.Clin Infect Dis,2000,31(4):859-868.
|
| 30. |
Pogrebniak HW,Gallin JI,Malech HL,et al.Surgical management of pulmonary infections in chronic granulomatous disease of childhood.Ann Thorac Surg,1993,55(4):844-849.
|
| 31. |
Kauffman CA.Quandary about treatment of aspergillomas persists.Lancet,1996,347(9016):1640.
|
| 32. |
Gossot D,Validire P,Vaillancourt R,et al.Full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis.Ann Thorac Surg,2002,73(1):240-244.
|
| 33. |
Bernard A,Caillot D,Couaillier JF,et al.Surgical management of invasive pulmonary aspergillosis in neutropenic patients.Ann Thorac Surg,1997,64(5):1441-1447.
|
